Company Filing History:
Years Active: 2012
Title: Innovations of Srishakumar Basawannappa Hadimani
Introduction
Srishakumar Basawannappa Hadimani is an accomplished inventor based in Oak Creek, Wisconsin. He has made significant contributions to the field of pharmacology through his innovative research and development of compounds that activate cholinergic receptors. His work is particularly relevant in the context of neurological studies and potential therapeutic applications.
Latest Patents
Hadimani holds a patent for "Compounds capable of activating cholinergic receptors." This patent includes a variety of compounds incorporating aryl substituted olefinic amines. Some representative compounds from his patent are (4E)-N-methyl-5-(3-pyridyl)-4-penten-2-amine, (4E)-N-methyl-5-(5-pyrimidinyl)-4-penten-2-amine, and (4E)-N-methyl-5-(5-methoxy-3-pyridyl)-4-penten-2-amine, among others. These compounds have the potential to play a crucial role in advancing medical treatments.
Career Highlights
Hadimani is currently associated with Targacept, Inc., where he continues to explore innovative solutions in the pharmaceutical industry. His work has not only contributed to the company's portfolio but has also enhanced the understanding of cholinergic receptor activation.
Collaborations
Throughout his career, Hadimani has collaborated with notable colleagues such as William Scott Caldwell and Gary Maurice Dull. These collaborations have fostered a productive environment for research and development, leading to advancements in their respective fields.
Conclusion
Srishakumar Basawannappa Hadimani's contributions to the field of pharmacology through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for future advancements in medical science.